These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35326625)

  • 21. Profiling specific cell populations within the inflammatory tumor microenvironment by oscillating-gradient diffusion-weighted MRI.
    Hoffmann E; Gerwing M; Niland S; Niehoff R; Masthoff M; Geyer C; Wachsmuth L; Wilken E; Höltke C; Heindel WL; Hoerr V; Schinner R; Berger P; Vogl T; Eble JA; Maus B; Helfen A; Wildgruber M; Faber C
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36918222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic Tumor Microenvironment.
    Wang K; He H
    Adv Exp Med Biol; 2020; 1296():243-257. PubMed ID: 34185297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adding combination immunotherapy consisting of cancer vaccine, anti-PD-1 and anti-CSF1R antibodies to gemcitabine improves anti-tumor efficacy in murine model of pancreatic ductal adenocarcinoma.
    Saung MT; Zheng L
    Ann Pancreat Cancer; 2019 Dec; 2():. PubMed ID: 32405624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry.
    Brouwer TP; de Vries NL; Abdelaal T; Krog RT; Li Z; Ruano D; Fariña A; Lelieveldt BPF; Morreau H; Bonsing BA; Vahrmeijer AL; Koning F; de Miranda NFCC
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer.
    Griesmann H; Drexel C; Milosevic N; Sipos B; Rosendahl J; Gress TM; Michl P
    Gut; 2017 Jul; 66(7):1278-1285. PubMed ID: 27013602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-Parameter Quantitative Imaging of Tumor Microenvironments Reveals Perivascular Immune Niches Associated With Anti-Tumor Immunity.
    Stoltzfus CR; Sivakumar R; Kunz L; Olin Pope BE; Menietti E; Speziale D; Adelfio R; Bacac M; Colombetti S; Perro M; Gerner MY
    Front Immunol; 2021; 12():726492. PubMed ID: 34421928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer.
    Ye J; Mills BN; Qin SS; Garrett-Larsen J; Murphy JD; Uccello TP; Han BJ; Vrooman TG; Johnston CJ; Lord EM; Belt BA; Linehan DC; Gerber SA
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35851308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reshaping the Immune Microenvironment by Oncolytic Herpes Simplex Virus in Murine Pancreatic Ductal Adenocarcinoma.
    Zhang L; Wang W; Wang R; Zhang N; Shang H; Bi Y; Chen D; Zhang C; Li L; Yin J; Zhang H; Cao Y
    Mol Ther; 2021 Feb; 29(2):744-761. PubMed ID: 33130310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer.
    Sadozai H; Acharjee A; Eppenberger-Castori S; Gloor B; Gruber T; Schenk M; Karamitopoulou E
    Front Immunol; 2021; 12():643529. PubMed ID: 33679807
    [No Abstract]   [Full Text] [Related]  

  • 30. Targeting alveolar macrophages shows better treatment response than deletion of interstitial macrophages in EGFR mutant lung adenocarcinoma.
    Alikhanyan K; Chen Y; Kraut S; Sotillo R
    Immun Inflamm Dis; 2020 Jun; 8(2):181-187. PubMed ID: 32125091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic effect of Abraxane that combines human IL15 fused with an albumin-binding domain on murine models of pancreatic ductal adenocarcinoma.
    Hsu FT; Tsai CL; Chiang IT; Lan KH; Yueh PF; Liang WY; Lin CS; Chao Y; Lan KL
    J Cell Mol Med; 2022 Apr; 26(7):1955-1968. PubMed ID: 35174623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy.
    Jiang H; Hegde S; Knolhoff BL; Zhu Y; Herndon JM; Meyer MA; Nywening TM; Hawkins WG; Shapiro IM; Weaver DT; Pachter JA; Wang-Gillam A; DeNardo DG
    Nat Med; 2016 Aug; 22(8):851-60. PubMed ID: 27376576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV16 tumor associated macrophages suppress antitumor T cell responses.
    Lepique AP; Daghastanli KR; Cuccovia IM; Villa LL
    Clin Cancer Res; 2009 Jul; 15(13):4391-400. PubMed ID: 19549768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF-β Alters the Proportion of Infiltrating Immune Cells in a Pancreatic Ductal Adenocarcinoma.
    Trebska-McGowan K; Chaib M; Alvarez MA; Kansal R; Pingili AK; Shibata D; Makowski L; Glazer ES
    J Gastrointest Surg; 2022 Jan; 26(1):113-121. PubMed ID: 34260016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of gender-associated M2-like tumor-associated macrophages in the tumor microenvironment of patients with pancreatic cancer after neoadjuvant chemoradiotherapy.
    Matsuki H; Hiroshima Y; Miyake K; Murakami T; Homma Y; Matsuyama R; Morioka D; Kurotaki D; Tamura T; Endo I
    J Hepatobiliary Pancreat Sci; 2021 Feb; 28(2):174-182. PubMed ID: 33316125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting Macrophages with CAR T Cells Delays Solid Tumor Progression and Enhances Antitumor Immunity.
    Sánchez-Paulete AR; Mateus-Tique J; Mollaoglu G; Nielsen SR; Marks A; Lakshmi A; Khan JA; Wilk CM; Pia L; Baccarini A; Merad M; Brown BD
    Cancer Immunol Res; 2022 Nov; 10(11):1354-1369. PubMed ID: 36095236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined MEK inhibition and tumor-associated macrophages depletion suppresses tumor growth in a triple-negative breast cancer mouse model.
    Zhang Q; Le K; Xu M; Zhou J; Xiao Y; Yang W; Jiang Y; Xi Z; Huang T
    Int Immunopharmacol; 2019 Nov; 76():105864. PubMed ID: 31480004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discrepancies in the Tumor Microenvironment of Spontaneous and Orthotopic Murine Models of Pancreatic Cancer Uncover a New Immunostimulatory Phenotype for B Cells.
    Spear S; Candido JB; McDermott JR; Ghirelli C; Maniati E; Beers SA; Balkwill FR; Kocher HM; Capasso M
    Front Immunol; 2019; 10():542. PubMed ID: 30972056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway.
    Sun L; Zhang X; Song Q; Liu L; Forbes E; Tian W; Zhang Z; Kang Y; Wang H; Fleming JB; Pasche BC; Zhang W
    Cancer Lett; 2021 Mar; 500():132-146. PubMed ID: 33309859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage Polarization.
    Chandrakesan P; Panneerselvam J; May R; Weygant N; Qu D; Berry WR; Pitts K; Stanger BZ; Rao CV; Bronze MS; Houchen CW
    Mol Cancer Ther; 2020 Jul; 19(7):1539-1549. PubMed ID: 32371580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.